Table 2 Characteristics of HLA-B7 LRH-1... | American Society of Hematology

Table 2

Characteristics of HLA-B7⁺ LRH-1⁺ patients who received a transplant from an LRH-1⁻ donor

Patient (Pt)	Diagnosis	Type of DLI	Sample date, wk after DLI	Presence of LRH-1–specific CD8⁺ T cells	LRH-1–specific CD8⁺ T cells (%) in sample	LRH-1–specific CD8⁺ T cells (%) after 2 weeks of culture
1	CML	Therapeutic	25	+	1.6	12.8
2	CML	Therapeutic	11	+	0.1	0.7
3	AML	Preemptive	10	+	6.9	15.4
4	AML	Preemptive	18	−	< 0.01	< 0.01
5	B-ALL	Preemptive	11	−	< 0.01	< 0.01
6	T-ALL	Preemptive	19	−	< 0.01	n.d.
7	MM	Preemptive	12	−	< 0.01	< 0.01

Patient (Pt)	Diagnosis	Type of DLI	Sample date, wk after DLI	Presence of LRH-1–specific CD8⁺ T cells	LRH-1–specific CD8⁺ T cells (%) in sample	LRH-1–specific CD8⁺ T cells (%) after 2 weeks of culture
1	CML	Therapeutic	25	+	1.6	12.8
2	CML	Therapeutic	11	+	0.1	0.7
3	AML	Preemptive	10	+	6.9	15.4
4	AML	Preemptive	18	−	< 0.01	< 0.01
5	B-ALL	Preemptive	11	−	< 0.01	< 0.01
6	T-ALL	Preemptive	19	−	< 0.01	n.d.
7	MM	Preemptive	12	−	< 0.01	< 0.01

n.d. indicates not determined.